NEW HAYESBANK SURGERY — All Prescriptions & Medications — Page 10
Practice Code: G82087 | ASHFORD, TN24 9JZ
Showing results 451-500 of 686
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olopatadine | 40 | 325 | £315 | -8.8% ▼ |
| Amiloride hydrochloride | 39 | 2,884 | £1.4K | +54.9% ▲ |
| Fluvastatin sodium | 39 | 1,120 | £329 | +68.6% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 39 | 193.4K | £2.1K | -10.9% ▼ |
| Acetazolamide | 39 | 5,068 | £195 | +80.0% ▲ |
| Exemestane | 38 | 1,440 | £271 | +16.9% ▲ |
| Pimecrolimus | 38 | 1,700 | £1.0K | +124.4% ▲ |
| 38 | 115 | £1.1K | +219.2% ▲ | |
| 38 | 413 | £1.2K | +114.2% ▲ | |
| Rasagiline mesilate | 37 | 1,456 | £996 | -0.4% vs avg |
| Zuclopenthixol hydrochloride | 36 | 3,600 | £276 | +14.2% ▲ |
| Lofepramine hydrochloride | 36 | 2,212 | £940 | +20.3% ▲ |
| Febuxostat | 36 | 1,288 | £252 | -3.6% ▼ |
| Betamethasone sodium phosphate | 36 | 375 | £89 | +39.0% ▲ |
| 36 | 128 | £806 | +16.1% ▲ | |
| 36 | 39 | £7.4K | +0.8% vs avg | |
| Bempedoic acid/Ezetimibe | 35 | 1,155 | £2.2K | -42.7% ▼ |
| Menthol | 35 | 14.4K | £516 | +24.3% ▲ |
| Telmisartan with diuretic | 34 | 1,876 | £737 | +200.7% ▲ |
| Ethosuximide | 34 | 11.7K | £14.9K | +130.5% ▲ |
| Glucagon | 34 | 40 | £462 | +123.5% ▲ |
| Bicalutamide | 34 | 1,512 | £102 | +5.1% ▲ |
| Benzoyl peroxide | 34 | 5,470 | £482 | +141.3% ▲ |
| Alkyl sulphate | 34 | 8,971 | £223 | +267.9% ▲ |
| 34 | 470 | £889 | +31.2% ▲ | |
| 34 | 4,260 | £2.0K | +172.4% ▲ | |
| Enalapril maleate with diuretic | 33 | 1,750 | £1.2K | +243.3% ▲ |
| Saxagliptin | 33 | 1,848 | £2.0K | -1.3% vs avg |
| Sodium feredetate | 33 | 13.8K | £393 | +15.2% ▲ |
| Pyridostigmine bromide | 33 | 6,600 | £514 | +92.8% ▲ |
| Light liquid paraffin | 33 | 16.2K | £285 | -3.1% ▼ |
| 33 | 272 | £300 | +6.0% ▲ | |
| 33 | 380 | £576 | +0.5% vs avg | |
| 33 | 1,824 | £255 | +12.3% ▲ | |
| Denosumab | 32 | 32 | £5.9K | +17.6% ▲ |
| 32 | 1,724 | £319 | +58.2% ▲ | |
| Clonidine hydrochloride | 31 | 2,264 | £176 | +69.7% ▲ |
| Naftidrofuryl oxalate | 31 | 3,528 | £426 | -4.9% ▼ |
| 31 | 6,252 | £220 | -37.9% ▼ | |
| 31 | 390 | £1.2K | +0.9% vs avg | |
| 31 | 960 | £6.7K | +144.5% ▲ | |
| Zinc oxide | 30 | 740 | £106 | +45.0% ▲ |
| Entacapone | 30 | 5,816 | £1.2K | +96.8% ▲ |
| Biphasic insulin lispro | 30 | 400 | £2.5K | -30.1% ▼ |
| Testosterone undecanoate | 30 | 38 | £3.3K | +18.1% ▲ |
| Alprostadil | 30 | 226 | £2.6K | +75.4% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914011) | 30 | 367.0K | £7.0K | +159.6% ▲ |
| Ivermectin | 30 | 1,590 | £924 | +41.1% ▲ |
| Heparinoid | 30 | 1,550 | £118 | +130.0% ▲ |
| 30 | 340 | £526 | +174.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.